Analysis of anti-cancer chemicals and pharmaceutical formulations

Ended Awarded Last action

Contract number
HHSN261201700014I
Awardee
Awarding agency
Task orders
9 $232,120 obligated

Award facts

Opportunity
Combined order value
$232,120 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 5% used
$5,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
The objective of this project is to provide services, personnel, equipment and facilities as required to perform… 75N91020F00004 National Cancer Institute (NIH) $25,686
Analysis for NSC 726188 (3 lots): appearance, proton NMR, infrared, hplc* (assay, impurity), moisture (KF). POP is… 75N91020F00003 National Cancer Institute (NIH) $37,708
This requirement is to perform the release analysis (appearance, PMR, IR, hplc* (assay; impurity), moisture, residual… 75N91020F00002 National Cancer Institute (NIH) $35,253
Analysis of the following: appearance, proton NMR, infrared, hplc (assay, impurity), residual solvents, moisture… 75N91020F00001 National Cancer Institute (NIH) $26,166
Analysis of bulk drug lot NSC 777586 75N91019F00129 National Cancer Institute (NIH) $24,873
To#4 quality control analysis of 1 lot LMP744 (CT018-401-424-015) , DTP-19-003, HHSN261201700014I, analysis of… 75N91019F00073 National Cancer Institute (NIH) $25,858
Next fdcyd_THU NSC112907 (CT029-402-448-003), to#3 milestone 2 - THU bulk drug analysis, DTP-18-026, HHSN261201700014I… 75N91018F00003 National Cancer Institute (NIH) $23,454
Stability study of NSC 777586 (AZA-t-dcyd) HHSN26100002 National Cancer Institute (NIH) $32,227
Admin costs - contract orientation & kick off MTG, DTP-17-039, 08/01/17 - 09/30/17, HHSN261201700014I, analysis of… HHSN26100001 National Cancer Institute (NIH) $895

Transactions

Action Obligated Date
Other Administrative Action P00001 · Analysis of anti-cancer chemicals and pharmaceutical formulations. POP: 08/01/2017 to 07/31/2022. $0
Original award $0

Quick answers

Who was awarded contract HHSN261201700014I?

HHSN261201700014I was awarded to Sri International by National Cancer Institute (National Institutes of Health) on August 1, 2017.

How much is contract HHSN261201700014I worth?

Orders under HHSN261201700014I have obligated $232,120. HHSN261201700014I's own ceiling is $5,000,000.

How many orders have been placed under contract HHSN261201700014I?

9 orders have been placed under HHSN261201700014I, the latest on July 15, 2020.

Who can order from contract HHSN261201700014I?

HHSN261201700014I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201700014I part of a contract vehicle?

Yes. HHSN261201700014I is part of NIH Analysis of Anti-Cancer Chemicals 2017-2022.

Was contract HHSN261201700014I competed?

The extent of competition for HHSN261201700014I was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login